Literature DB >> 17874044

In situ production of sex steroids in human breast carcinoma.

Takashi Suzuki1, Yasuhiro Miki, Takuya Moriya, Jun-Ichi Akahira, Hisashi Hirakawa, Noriaki Ohuchi, Hironobu Sasano.   

Abstract

It is well known that sex steroids are closely involved in the growth of human breast carcinomas, and the great majority of breast carcinomas express sex steroid receptors. In particular, recent studies have demonstrated that estrogens and androgens are locally produced and act in breast carcinoma tissues without release into plasma. Blockade of intratumoral estrogen production potentially leads to an improvement in the prognosis of invasive breast carcinoma patients, and, therefore, it is important to obtain a better understanding of sex steroid-producing enzymes in breast carcinoma. In this review, we summarize recent studies on tissue concentration of sex steroids and expression of enzymes related to intratumoral production of estrogens [aromatase, steroid sulfatase (STS), and 17beta-hydroxysteroid dehydrogenase type 1 (17betaHSD1)], and androgens (17betaHSD5 and 5alpha-reductase) in invasive and in situ (noninvasive) breast carcinomas, and discuss the significance of intratumoral production of sex steroids in breast carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17874044     DOI: 10.1007/s00795-007-0365-8

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.070


  69 in total

Review 1.  MRI of the breast: comparison of MRI signals and histological characteristics of the same slices.

Authors:  Ritsu Kusama; Fumiyoshi Takayama; Shin-ichi Tsuchiya
Journal:  Med Mol Morphol       Date:  2005-12       Impact factor: 2.309

2.  Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors.

Authors:  A G A Selim; G El-Ayat; C A Wells
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

3.  5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production.

Authors:  Takashi Suzuki; Yasuhiro Miki; Takuya Moriya; Jun-ichi Akahira; Takanori Ishida; Hisashi Hirakawa; Yuri Yamaguchi; Shin-ichi Hayashi; Hironobu Sasano
Journal:  Int J Cancer       Date:  2007-01-15       Impact factor: 7.396

4.  Intratumoral aromatase as a prognostic factor in human breast carcinoma.

Authors:  M C Silva; M G Rowlands; M Dowsett; B Gusterson; J A McKinna; I Fryatt; R C Coombes
Journal:  Cancer Res       Date:  1989-05-15       Impact factor: 12.701

5.  Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.

Authors:  Christopher I Li; Janet R Daling; Kathleen E Malone
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-04       Impact factor: 4.254

Review 6.  Steroid sulfatase: molecular biology, regulation, and inhibition.

Authors:  M J Reed; A Purohit; L W L Woo; S P Newman; B V L Potter
Journal:  Endocr Rev       Date:  2004-11-23       Impact factor: 19.871

7.  Significance of aromatase activity in human breast cancer.

Authors:  W R Miller; R A Hawkins; A P Forrest
Journal:  Cancer Res       Date:  1982-08       Impact factor: 12.701

Review 8.  The selective estrogen enzyme modulators in breast cancer: a review.

Authors:  Jorge R Pasqualini
Journal:  Biochim Biophys Acta       Date:  2004-06-07

9.  Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer.

Authors:  T Utsumi; N Yoshimura; S Takeuchi; J Ando; M Maruta; K Maeda; N Harada
Journal:  Cancer Res       Date:  1999-01-15       Impact factor: 12.701

10.  Semi-quantitative immunohistochemical analysis of aromatase expression in ductal carcinoma in situ of the breast.

Authors:  Zhenhuan Zhang; Hiroko Yamashita; Tatsuya Toyama; Yasuo Hara; Yoko Omoto; Hiroshi Sugiura; Shunzo Kobayashi; Nobuhiro Harada; Hirotaka Iwase
Journal:  Breast Cancer Res Treat       Date:  2002-07       Impact factor: 4.872

View more
  14 in total

Review 1.  Molecular therapy of breast cancer: progress and future directions.

Authors:  Sheng-Xiang Lin; Jiong Chen; Mausumi Mazumdar; Donald Poirier; Cheng Wang; Arezki Azzi; Ming Zhou
Journal:  Nat Rev Endocrinol       Date:  2010-07-20       Impact factor: 43.330

2.  Intratumoral estrogen sulfotransferase induction contributes to the anti-breast cancer effects of the dithiocarbamate derivative TM208.

Authors:  Xi-wei Ji; Guang-ping Chen; Yan Song; Ming Hua; Li-jie Wang; Liang Li; Yin Yuan; Si-yuan Wang; Tian-yan Zhou; Wei Lu
Journal:  Acta Pharmacol Sin       Date:  2015-05-04       Impact factor: 6.150

3.  Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors.

Authors:  Ulla Simanainen; Yan Ru Gao; Kirsty A Walters; Geoff Watson; Reena Desai; Mark Jimenez; David J Handelsman
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

Review 4.  Structural and Functional Biology of Aldo-Keto Reductase Steroid-Transforming Enzymes.

Authors:  Trevor M Penning; Phumvadee Wangtrakuldee; Richard J Auchus
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 5.  Androgens in human breast carcinoma.

Authors:  Takashi Suzuki; Yasuhiro Miki; Kiyoshi Takagi; Hisashi Hirakawa; Takuya Moriya; Noriaki Ohuchi; Hironobu Sasano
Journal:  Med Mol Morphol       Date:  2010-08-04       Impact factor: 2.309

6.  Testosterone membrane-initiated action in breast cancer cells: Interaction with the androgen signaling pathway and EPOR.

Authors:  Vassiliki Pelekanou; George Notas; Elias Sanidas; Andreas Tsapis; Elias Castanas; Marilena Kampa
Journal:  Mol Oncol       Date:  2010-02-02       Impact factor: 6.603

7.  The Role of Androgens in Normal and Malignant Breast Tissue.

Authors:  Katharina Tiefenbacher; Günter Daxenbichler
Journal:  Breast Care (Basel)       Date:  2008-10-16       Impact factor: 2.860

Review 8.  Promiscuity and diversity in 3-ketosteroid reductases.

Authors:  Trevor M Penning; Mo Chen; Yi Jin
Journal:  J Steroid Biochem Mol Biol       Date:  2014-12-10       Impact factor: 4.292

Review 9.  AKR1C3 (type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase): Roles in malignancy and endocrine disorders.

Authors:  Trevor M Penning
Journal:  Mol Cell Endocrinol       Date:  2018-09-19       Impact factor: 4.102

10.  Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.

Authors:  Jiaqi Fu; Amy M Weise; Josie L Falany; Charles N Falany; Bryan J Thibodeau; Fred R Miller; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Breast Cancer Res Treat       Date:  2009-03-24       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.